1 |
Denosumab |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [7] 46, 50, 93, 95, 96, 274, 299 💬 |
2 |
Denosumab - - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
3 |
Denosumab - immunoglobulin g2 human monoclonal antibody to rank ligand |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
274 [1] 274 💬 |
4 |
Pralia 60 mg subcutaneous injection syringe(denosumab) |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |
5 |
Pralia 60mg subcutaneous injection syringe(denosumab) |
Denosumab |
[1] D03684 D03684 💬 |
TNFSF11 [1] TNFSF11 💬 |
Breast cancer [7] Breast cancer, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis |
046 [1] 46 💬 |